Andrew Steele joined Ropes & Gray's litigation department in 2021. Andrew's practice focuses on complex commercial disputes, shareholder derivative and securities litigation, and white-collar investigations. He has worked with a range of clients including innovative public and private companies and major financial institutions. Andrew maintains an active pro bono practice, including representing a Massachusetts community services organization in employment matters. During law school, Andrew served as an executive editor for the Cornell Journal of Law and Public Policy and as a bench editor on the Cornell Moot Court Board.

Experience

Securities Litigation:

  • Represented New York-based biopharmaceutical startup in S.D.N.Y. securities class action related to oncology drug development, secured dismissal with prejudice.
  • Representing cybersecurity firm in N.D. Cal. securities class action related to statements by company executives.
  • Representing premium cosmetics brand in C.D. Cal. securities class action premised on allegedly misleading offering documents.
  • Representing national health care provider in S.D.N.Y. securities class action premised on allegedly misleading offering documents.

Other Civil Litigation:

  • Represented public company in AAA commercial arbitration related to acquisition of high technology manufacturer.
  • Represented biopharmaceutical startup in AAA commercial arbitration arising out of disclosure of confidential information.
  • Representing biopharmaceutical manufacturer in litigation related to vaccine manufacturing across multiple jurisdictions.
  • Representing investment firm in connection with major cryptocurrency litigation.
  • Representing alternative investment firm in New York state court bond indenture dispute.

SEC and Internal Investigations:

  • Successfully represented private equity firm in SEC investigation related to now-closed SPAC transaction.
  • Successfully represented leading investment bank in SEC investigation involving fund valuation.
  • Representing leading investment bank in SEC investigation related to SPAC transactions.
  • Advising multinational pharmaceutical companies on compliance risks.

Pro bono:

  • Secured dismissal of employment claim against community services organization in Massachusetts state court.

Other:

  • Advised private organization on investment management practices.
  • Advising New York health care fund in administrative dispute.
  • Representing leading investment management company in various third-party litigation matters.

Areas of Practice